Renerval Biotherapeutics
Latest round
- Angel
Last raised
- Dec 2022
Total raised
- Undisclosed
Investors
- 2
About Renerval Biotherapeutics
, dba Renerval Biotherapeutics, is a biotechnology company focusing on building an artificial blood preparation platform and simultaneously constructing a globally leading regenerative medicine cell product development system based on iPSC (Induced Pluripotent Stem Cell) technology. The company was founded by Dr. Wenyuan Wang, a postdoctoral fellow at the Massachusetts Institute of Technology (MIT), a researcher at the Institute of Organic Chemistry of the Chinese Academy of Sciences (CAS) and the Biological and Chemical Intersection Research Center of CAS, and a double-appointed professor at Huashan Hospital of Fudan University. Renerval Biotherapeutics has, relying on core technology system, covering key technologies such as iPSC cell reprogramming, precision gene editing, directed differentiation, and organoid engineering, created a product matrix includes high-end blood bioproducts such as universal artificial regenerated platelets and artificial red blood cells which is applicable to essential transfusion scenarios such as thrombocytopenia from cancer chemotherapy, severe hematological diseases, major surgical procedures, trauma emergency care, and perioperative support. The company generates revenue by providing cell therapy solutions, including the production of clinical-grade regenerated platelet cells, and by driving the development of other novel products and pipelines in the field of cellular therapeutics. In the future, the company will fully integrate industry resources, domestic and international clinical application channels, and a global business ecosystem to comprehensively empower its pipeline for rapid iteration and industrialization.
Who invested in Renerval Biotherapeutics
2 investors across 2 rounds
See all investors in Renerval Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Renerval Biotherapeutics
Who invested in Renerval Biotherapeutics?
Renerval Biotherapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Renerval Biotherapeutics raised?
Renerval Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Renerval Biotherapeutics last raise money?
Renerval Biotherapeutics's most recent round on record is a Angel, in Dec 2022.
What does Renerval Biotherapeutics do?
, dba Renerval Biotherapeutics, is a biotechnology company focusing on building an artificial blood preparation platform and simultaneously constructing a globally leading regenerative medicine cell product development system based on iPSC (Induced Pluripotent Stem Cell) technology.
Where is Renerval Biotherapeutics headquartered?
Renerval Biotherapeutics is headquartered in Shanghai, China.
Which VCs invest in companies like Renerval Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Renerval Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Renerval Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.